Skip to main content

Table 1 Racial differences in baseline* demographic and clinical status of diabetes patients (N = 1906)

From: Racial differences in long-term adherence to oral antidiabetic drug therapy: a longitudinal cohort study

  Black
N = 498 (26.1%)
White
N = 1408 (73.9%)
Demographic Characteristics   
Male 49.4 57.2
Mean Age (SD) 45(10) 53(13)
Census-Derived SES Measures   
Living in neighborhood with mean household income below poverty level 30.9 9.2
Living in neighborhood where >75% residents do not understand spoken English 32.4 13.6
Living in neighborhood where >75% residents do not have high school degree 5.6 0.8
Health Service Utilization   
Mean # of MD Visits (SD) 3(2) 3(2)
Mean # of Lab Tests (SD) 2(1) 2(1)
Clinical Characteristics   
Glycemic Control§   
   Good (<7.0%) 35.7 41.1
   Moderate (7.0%–9.0%) 44.4 45.4
   Poor (>9.0%) 19.9 13.6
Mean HbA1c Values§ (SD) 7.8(1.6) 7.6(1.5)
Body Mass Index (BMI)||   
   Overweight (30–<40) 42.6 48.6
   Obese (40+) 16.0 13.6
Mean BMI|| (SD) 33.2(7.6) 32.8(6.6)
Comorbidities   
Any Diabetes-Related Hospitalizations 8.6 10.8
Any Diabetes-Related ER Visits 9.4 9.2
Monthly Mean # AHFS (SD) 1.9(0.9) 2.1(1.0)
Self-Management Practice   
Initiation of Self-Monitoring Blood Glucose 70.7 59.6
Initiation of Medication Therapy   
   Sulfonylurea 86.7 85.8
   Metformin (alone or in combination) 13.2 14.2
  1. Data are expressed as % patients or mean (SD).
  2. *Baseline = 12 months prior to first drug prescription, not including the month of first script.
  3. p <.05.
  4. § Among those with a baseline HbA1c test (% with HbA1c data = Black: 34.3%; White: 41.3%)
  5. || Among those with a baseline BMI (% with BMI data = Black: 49.0%; White: 52.1%).
  6. AHFS = American Hospital Formulary Services.